Processa Pharmaceuticals, Inc. (PCSA) Insider Trading
Sector: Pharmaceuticals · Market Cap: $8M · 2 insider purchases in the last 7 days
| INSIDER | DATE | SHARES | PRICE | TOTAL VALUE | OWNED AFTER |
|---|---|---|---|---|---|
| Guy Wendy Chief Administrative Officer | May 15, 2026 | 1,583 | $2.97 | $5K | 8,011 |
| Ng George K CEO | May 15, 2026 | 1,843 | $2.97 | $5K | 7,841 |
Want more?
Sign up free to see 30+ days of history, set alerts, and track PCSA on your watchlist.
Start for FreeAbout Processa Pharmaceuticals, Inc. Insider Trading
5 insiders at Processa Pharmaceuticals, Inc. (PCSA) have purchased stock in the past 90 days, totaling $41K across 8 transactions (14,730 shares).
The most recent purchase was by Chief Administrative Officer Guy Wendy on May 15, 2026 — a $5K buy of 1,583 shares at $2.97, bringing his total holdings to 8,011 shares.
Insiders who purchased: Ng George K (CEO, 3 buys totaling $16K); Guy Wendy (Chief Administrative Officer, 2 buys totaling $9K); SKIBSTED RUSSELL (CFO, 1 buy totaling $6K); Bigora Sian (Chief Development Officer, 1 buy totaling $5K); Lin Patrick (Chief Business - Strategy Off, 1 buy totaling $4K).
This insider buying is notable given that PCSA had no recorded open market purchases in the nine months before that.
PCSA is in the Pharmaceuticals sector within the Pharmaceuticals industry with a market cap of $8M.
With 5 different insiders buying in the same 90-day window, this qualifies as cluster buying at PCSA — a pattern that research suggests can signal conviction among management.
Track PCSA insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.